Skip to main content
Equibles

HSBC HOLDINGS PLC

Position in PMVP — PMV Pharmaceuticals, Inc.

CIK 873630 LONDON, X0
Back to PMVP Full portfolio

Position in PMVP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$41,393
+$3,089 QoQ
Shares Held
30,891
0.0% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 64 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PMVP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. PMVP ranks #124 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 676,247 $335,912,169
2 REGN
Regeneron Pharmaceuticals, Inc.
 382,028 $238,209,735
3 INCY
Incyte Corp
 1,307,743 $148,245,744
4 RPRX
Royalty Pharma plc
 1,224,925 $68,681,542
5 MRNA
Moderna, Inc.
 636,199 $44,553,014
6 ALNY
Alnylam Pharmaceuticals, Inc.
 115,279 $34,702,435
7 INSM
INSMED Inc
 279,961 $29,849,438
8 BMRN
Biomarin Pharmaceutical Inc
 307,543 $17,597,610

All Filings in PMVP

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $41,393 30,891
2026-03-31 $38,304 30,891
2025-12-31 $38,613 30,891
2025-09-30 $43,247 30,891
2025-06-30 $32,744 30,891
2025-03-31 $33,671 30,891
2024-12-31 $59,010 39,080
2024-09-30 $58,229 39,080
2024-06-30 $70,815 43,713
2024-03-31 $74,312 43,713
2023-12-31 $121,144 39,079
2023-09-30 $188,369 30,679
2023-06-30 $244,490 39,056
2023-03-31 $133,574 28,003